CTC Adverse Event Guidelines

Under the Cancer Therapy Evaluation Program (CTEP) of the National Cancer Institute, guidelines have been developed to evaluate treatment-related Adverse Events (AEs), with the caveat that the AEs are associated with the treatment but may or may not be a consequence of the treatment. The following is the latest version of the CTCAE (Common Terminology Criteria for Adverse Events).